PolyPeptide Group AG Financials

Market Capitalization CHF692.9 Million as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	108.52
Forward PE	56.76
Price to Sales TTM	CHF2.06
Price to Book MRQ	CHF1.94
Enterprise to Revenue	2.08
Enterprise to EBITDA	38.38

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-12-31
Profit Margin	-5.81%
Operating Margin	3.28%
Return on Assets TTM	-0.51%
Return on Equity TTM	-5.30%

Income Statement

Revenue TTM	CHF314,799,485
Revenue per Share TTM	CHF10.21
Quarterly Revenue Growth	7.00%
Gross Profit TTM	CHF35,038,164
EBITDA	CHF29,786,000
Net Income to Common TTM	CHF-18,286,470
Diluted EPS TTM	CHF-0.55
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	CHF63,818,512
Total Cash per Share MRQ	CHF2.07
Total Debt MRQ	CHF
Total Debt to Equity MRQ	29.36
Current Ratio MRQ	1.69
Book Value per Share MRQ	CHF10.83

Cash Flow

Operating Cash Flow TTM	CHF83,561,246
Levered Free Cash Flow TTM	CHF-63,517,770

PPGN Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	32,996,496
Float Shares	12,939,246
Avg 10 Volume	19,326
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	60.48%
% Held by Institutions	23.62%

Stock Price Summary

Beta	1.11
Fifty Two Week Low	CHF13.22
Fifty Two Week High	CHF35.80
Fifty Two Week Change	-49.05%
Day 50 MA	CHF19.89
Day 200 MA	CHF23.80

Dividends and Splits

Forward Annual Dividend Rate	CHF
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	CHF0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	2022-05-02
Ex Dividend Date	2022-04-28
Last Split Factor
Last Split Date